Skip to main content
. 2022 Sep 7;10(5):e02257-22. doi: 10.1128/spectrum.02257-22

FIG 1.

FIG 1

Selection of participants and testing. This study involved persons who were fully vaccinated with two doses of BNT162b2 or mRNA-1273, and persons who received one dose of BNT162b2 as booster after being vaccinated with two doses of BNT162b2 before April 5, 2022.